Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia

Affiliations

• ¹ Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec.
• ² Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada; Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec.
• ³ Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec.
• ⁴ Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec.
• ⁵ Department of Pathology, CHU Sainte-Justine, Montréal, Québec.
• ⁶ Department of Medical Imaging, Nuclear Medicine, CHU Sainte-Justine, Montréal, Québec.
• ⁷ Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada; Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec. thai.hoa.tran@umontreal.ca.